Jump to content

Serdar Bulun

From Wikipedia, the free encyclopedia
(Redirected from Draft:Serdar Bulun)
Serdar Bulun
Born
Malatya, Turkey
Scientific career
Fields
Institutions
Websitehttp://www.feinberg.northwestern.edu/sites/obgyn/research/labs/bulun/index.html

Serdar Bulun is a gynecologist, with a special interest in the common gynecologic diseases, endometriosis and uterine fibroids.[1][2][3][4][5]

Biography

[edit]

Bulun was born in Malatya, Turkey in 1959 and moved to Istanbul to attend Robert College and thereafter Istanbul University School of Medicine (Çapa Tıp Fakültesi). He completed his residency in obstetrics and gynecology at the University at Buffalo in New York and pursued a sub-specialty fellowship in reproductive endocrinology-infertility at the University of Texas Southwestern Medical Center at Dallas. Starting from 2003, he established a comprehensive women’s health research program at Northwestern, and recruited and supported numerous faculty who focus on steroid hormone-related pathology of uterine, breast and ovarian disorders.[6] Throughout his career, Dr. Bulun has been awarded over $70 million of research funding in endometriosis, uterine fibroids and breast cancer.[3][4][5][6][7][8][9][10][11][12]

Academic career

[edit]

Bulun discovered the epigenetic basis of endometriosis leading to progesterone resistance in this disease, and introduced aromatase inhibitors as a novel class of drugs to treat it.[1][3][5][11] His team isolated tumor stem cells from uterine fibroids and targeted these to treat this disease.[2][4][6][10] His team discovered the first set of gain-of-function mutations affecting the aromatase gene leading to breast development and estrogen excess in prepubertal humans and contributed to the genetics and systems biology aspects of hormone-responsive disorders of the breast, including cancer.[7][8][9][12]

Bulun is the editor-in-chief of Seminars in Reproductive Medicine.[13] He has been elected to the National Academy of Medicine (formerly known as the Institute of Medicine), the Association of American Physicians and the American Society for Clinical Investigation.[14][15][16] He served as the 2015 president for the Society for Reproductive Investigation.[17] He has received the National Institutes of Health-MERIT award for his work in endometriosis and the American Society of Reproductive Medicine Distinguished Researcher Award.[18][19]

Honors

[edit]

References

[edit]
  1. ^ a b Bulun, SE (2009). "Endometriosis". N Engl J Med. 360 (3): 268–79. doi:10.1056/NEJMra0804690. PMID 19144942.
  2. ^ a b Bulun, SE (2013). "Uterine fibroids". N Engl J Med. 369 (14): 1344–55. doi:10.1056/NEJMra1209993. PMID 24088094.
  3. ^ a b c Attar E, Bulun SE. Aromatase inhibitors: the next generation of therapeutics for endometriosis?Fertil Steril.2006;85:1307-18.
  4. ^ a b c Ono M, Yin P, Navarro A, et al. Paracrine activation of WNT/beta-catenin pathway in uterine leiomyoma stem cells promotes tumor growth.Proc Natl Acad Sci USA.2013;110:17053-8.
  5. ^ a b c Dyson MT, Roqueiro D, Monsivais D, et al. Genome-wide DNA methylation analysis predicts an epigenetic switch for GATA factor expression in endometriosis.PLoS Genet.2014;10(3):e1004158.
  6. ^ a b c Kim, JJ; Kurita, T; Bulun, SE (2013). "Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer". Endocr Rev. 34 (1): 130–62. doi:10.1210/er.2012-1043. PMC 3565104. PMID 23303565.
  7. ^ a b Bulun SE, Lin Z, Imir G, et al. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment.Pharmacol Rev.2005;57:359-83.
  8. ^ a b Shozu M, Sebastian S, Takayama K, et al. Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene.N Engl J Med.2003;348:1855-65.
  9. ^ a b Demura M, Martin RM, Shozu M, et al. Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene.Hum Mol Genet.2007;16:2529-41.
  10. ^ a b Ono, M; Qiang, W; Serna, VA; Yin, P; Coon; Navarro, A; Monsivais, D; Kakinuma, T; Dyson, M; Druschitz, S; Unno, K; Kurita, T; Bulun, SE (2012). "Role of stem cells in human uterine leiomyoma growth". PLOS ONE. 7 (5): e36935. Bibcode:2012PLoSO...736935O. doi:10.1371/journal.pone.0036935. PMC 3343011. PMID 22570742.
  11. ^ a b Attia, GR; Zeitoun, K; Edwards, D; Johns, A; Carr, BR; Bulun, SE (2000). "Progesterone receptor isoform A but not B is expressed in endometriosis". J Clin Endocrinol Metab. 85 (8): 2897–902. doi:10.1210/jcem.85.8.6739. PMID 10946900.
  12. ^ a b Zhou J, Gurates B, Yang S, Sebastian S, Bulun SE. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.Cancer Res.2001;61:2328-34.
  13. ^ Bulun, S. E. (2015). "Thieme Medical Publishers". Seminars in Reproductive Medicine. 33 (6): 373–4. doi:10.1055/s-0035-1567816. PMID 26565385.
  14. ^ a b "News Center". Northwestern Medicine. 19 October 2015.
  15. ^ a b "Serdar E. Bulun, M.D." The American Society for Clinical Investigation.
  16. ^ a b "Member Directory". Association for American Physicians.
  17. ^ "SRI Presidents". Society for Reproductive Investigation.
  18. ^ a b "Endometriosis and Retinoids". Grantome.
  19. ^ a b "ASRM2012: Serdar Bulun honoured as distinguished researcher". endometriosis.org.
  20. ^ "Faculty Profiles". Northwestern Medicine.
  21. ^ "Bulun Appointed Gardner Clinical Professor". Northwestern University News Center.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Serdar_Bulun&oldid=1140132884"